Corcept Therapeutics Q4 Sales $87.9M Up From $66.831M YoY

Corcept Therapeutics (NASDAQ:CORT) reported $87.9 million in sales this quarter. This is a 31.53 percent increase over sales of $66.831 million the same period last year.

Benzinga · 01/30/2020 21:15

Corcept Therapeutics (NASDAQ:CORT) reported $87.9 million in sales this quarter. This is a 31.53 percent increase over sales of $66.831 million the same period last year.